A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

ClinicalTrials.gov ID: NCT06568627

Public ClinicalTrials.gov record NCT06568627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of Venous Leg Ulcers (VALUE)

Study identification

NCT ID: NCT06568627
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: MediWound Ltd; Industry
Enrollment: 216 participants

Conditions and interventions

Conditions

Venous Leg Ulcer (VLU)

Interventions

EscharEx (EX-03) Drug
Placebo (Gel vehicle) Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 31, 2025
Primary completion: Nov 30, 2026
Completion: Feb 28, 2027
Last update posted: Apr 1, 2026

2025 – 2027

United States locations

U.S. sites: 14
U.S. states: 7
U.S. cities: 13

Facility	City	State	ZIP	Site status
Limb Preservation Platform, Inc	Fresno	California	93710	Not yet recruiting
Angel City Research,Inc	Los Angeles	California	90010	Recruiting
Center for Clinical Research INC	San Francisco	California	94115	Recruiting
ILD Research Center	Vista	California	92081	Not yet recruiting
University of Miami	Miami	Florida	33136	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Boston Medical Center	Boston	Massachusetts	02118	Not yet recruiting
Rutgers New Jersey Medical Center	Newark	New Jersey	07103	Recruiting
Northwell Health Comprehensive Wound Healing Center	Lake Success	New York	11042	Active, not recruiting
NYU Langone Health Long Island - Research & Academic Center	Mineola	New York	11501	Recruiting
Mount Sinai West	New York	New York	10019	Recruiting
Cutting Edge Research LLC.,	Circleville	Ohio	43113	Recruiting
Clinical Trial Network Houston	Houston	Texas	77074	Recruiting
Woundcentrics, LLC	San Antonio	Texas	78251	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06568627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 1, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06568627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →